Healthcare - Biotechnology - NASDAQ - US
$ 41.11
0.171 %
$ 2.45 B
Market Cap
15.0
P/E
CASH FLOW STATEMENT
-70.2 M
OPERATING CASH FLOW
-39.3 M
INVESTING CASH FLOW
170 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Protagonist Therapeutics, Inc.
| Net Income | -79 M |
| Depreciation & Amortization | 3.31 M |
| Capital Expenditures | -609 K |
| Stock-Based Compensation | 29.3 M |
| Change in Working Capital | -19.5 M |
| Others | -21 M |
| Free Cash Flow | -70.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||
| Net Income | (79.0) | (127.4) | (125.6) | (66.2) | (77.2) | (38.9) | (37.0) | (37.2) | (14.9) | (11.1) |
| Depreciation & Amortization | 3.3 | 3.4 | 2.8 | 2.6 | 2.5 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 |
| Deferred Income Tax | 0 | 0 | 0 | 1.4 | (0.8) | (0.7) | 0 | 0.2 | 8 K | 0 |
| Stock Based Compensation | 29.3 | 24.2 | 16.4 | 7.9 | 8.4 | 6.9 | 4.2 | 2.1 | 99 K | 42 K |
| Other Operating Activities | (4.4) | (0.5) | 1.8 | 0.8 | (0.6) | 0.2 | 0.6 | 4.7 | 83 K | 1.8 |
| Change in Working Capital | (19.5) | (7.8) | (3.3) | (19.0) | 26.1 | (18.0) | 35.6 | (0.1) | 52 K | 1.3 |
| Cash From Operations | (70.2) | (108.1) | (107.9) | (72.5) | (41.5) | (49.9) | 3.9 | (30.0) | (14.4) | (7.7) |
| INVESTING CASH FLOW | ||||||||||
| Capital Expenditures | (0.6) | (0.8) | (1.1) | (0.5) | (1.0) | (0.5) | (0.7) | (0.4) | (0.4) | (0.3) |
| Other Items | (38.6) | 92.3 | (14.8) | (90.5) | (52.7) | 2.7 | 16.5 | (58.9) | (7.9) | 0 |
| Cash From Investing Activities | (39.3) | 91.5 | (15.9) | (91.0) | (53.7) | 2.2 | 15.8 | (59.3) | (8.3) | (0.3) |
| FINANCING CASH FLOW | ||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | (10.5) | 9.8 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 38.4 | 4.3 | 6.1 | 2.8 | 1.8 | 0.9 | 1.0 | 22.7 | 17.4 | 9.0 |
| Cash From Financing Activities | 170.5 | 18.8 | 129.9 | 247.6 | 46.0 | 24.1 | 65.6 | 106.3 | 17.4 | 9.0 |
| CHANGE IN CASH | ||||||||||
| Net Change In Cash | 61.0 | 2.1 | 6.1 | 84.4 | (49.2) | (23.8) | 85.4 | 17.0 | (5.3) | 0.9 |
| FREE CASH FLOW | ||||||||||
| Free Cash Flow | (70.8) | (108.9) | (109.0) | (73.0) | (42.5) | (50.4) | 3.2 | (30.4) | (14.8) | (8.0) |